Population studies performed in the 1970s identified high plasma apolipoprotein AI (apo AI) and HDL cholesterol (HDL-C) levels as powerful indicators of a low risk of coronary heart disease (CHD) and cerebrovascular disease [3,4], whereas high apo B and LDL-C indicate an increased risk of CHD and death. Here, APOA1 is linked to coronary artery disorder.